Literature DB >> 26735563

RETINAL LAYER RESPONSE TO RANIBIZUMAB DURING TREATMENT OF DIABETIC MACULAR EDEMA: Thinner is Not Always Better.

Andreas Ebneter1, Sebastian Wolf, Jain Abhishek, Martin S Zinkernagel.   

Abstract

PURPOSE: To identify individual retinal layer thickness changes associated with visual acuity gain in diabetic macular edema treated with ranibizumab using layer segmentation on high-resolution optical coherence tomography scans.
METHODS: Retrospective observational case series. Thirty-three treatment-naive eyes with diabetic macular edema were imaged by spectral domain optical coherence tomography at monthly visits while receiving intravitreal ranibizumab treatment as needed, guided by visual acuity. Thickness changes of individual layers after 1 year were quantitatively analyzed and correlated with visual acuity gain.
RESULTS: The mean best-corrected visual acuity improvement at 1 year was 6.2 (SEM ± 1.5) Early Treatment Diabetic Retinopathy Study letters, and central retinal thickness decreased by 66 ± 18 μm. In the central subfield, there was a significant decrease of thickness for all layers (P < 0.05) except the outer nuclear layer. Multiple linear regression analysis revealed that thickness decrease of the inner retina was associated with better visual acuity, whereas for the outer retina the opposite was true. The best estimate of final visual acuity (R = 0.817, P < 0.001) was obtained, by including baseline visual acuity and thickness change of the inner and outer plexiform layers in the model.
CONCLUSION: Whereas thickness decrease of the inner retina was positively associated with visual acuity gain, the opposite was found for the outer retina. This might be indirect evidence for recovery of the outer retina during ranibizumab treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26735563     DOI: 10.1097/IAE.0000000000000923

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  Impacts of intravitreal anti-VEGF therapy on retinal anatomy and neurophysiology in diabetic macular edema.

Authors:  Zübeyir Yozgat; Mustafa Doğan; Mehmet Cem Sabaner; Hamidu Hamisi Gobeka; Serpil Yazgan Akpolat
Journal:  Int Ophthalmol       Date:  2021-02-19       Impact factor: 2.031

2.  Visual acuity loss associated with excessive "dry macula" in exudative age-related macular degeneration.

Authors:  Hidenori Takahashi; Yuji Inoue; Xue Tan; Satoru Inoda; Shinichi Sakamoto; Yusuke Arai; Yasuo Yanagi; Yujiro Fujino; Hidetoshi Kawashima
Journal:  Clin Ophthalmol       Date:  2018-02-20

3.  Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema.

Authors:  Yoshiro Minami; Taiji Nagaoka; Akihiro Ishibazawa; Akitoshi Yoshida
Journal:  BMC Ophthalmol       Date:  2017-03-14       Impact factor: 2.209

4.  Optical Coherence Tomography Angiography in Mice: Comparison with Confocal Scanning Laser Microscopy and Fluorescein Angiography.

Authors:  Helena Giannakaki-Zimmermann; Despina Kokona; Sebastian Wolf; Andreas Ebneter; Martin S Zinkernagel
Journal:  Transl Vis Sci Technol       Date:  2016-08-18       Impact factor: 3.283

5.  ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study Data.

Authors:  Pravin U Dugel; Joanna H Campbell; Szilárd Kiss; Anat Loewenstein; Vanessa Shih; Xiaoshu Xu; Nancy M Holekamp; Albert J Augustin; Allen C Ho; Victor H Gonzalez; Scott M Whitcup
Journal:  Retina       Date:  2019-01       Impact factor: 4.256

6.  Correlation of Volume of Macular Edema with Retinal Tomography Features in Diabetic Retinopathy Eyes.

Authors:  Santosh Gopi Krishna Gadde; Arpita Kshirsagar; Neha Anegondi; Thirumalesh B Mochi; Stephane Heymans; Arkasubhra Ghosh; Abhijit Sinha Roy
Journal:  J Pers Med       Date:  2021-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.